Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights
IntroductionPediatric-onset multiple sclerosis (POMS) poses unique therapeutic challenges due to high inflammatory activity, early cognitive and psychosocial impact, and difficulties with long-term treatment adherence. This retrospective cohort study evaluated the real-world safety and clinical outc...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2026-05-01
|
| Serier: | Frontiers in Immunology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fimmu.2026.1727925/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|